SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-011414
Filing Date
2022-02-03
Accepted
2022-02-03 17:03:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm225246d2_424b5.htm 424B5 351654
2 GRAPHIC tm225246d2_424b5img001.jpg GRAPHIC 12900
3 GRAPHIC lg_titan-pharma.jpg GRAPHIC 12900
  Complete submission text file 0001104659-22-011414.txt   388511
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230742 | Film No.: 22589527
SIC: 2836 Biological Products, (No Diagnostic Substances)